Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort

Journal of the National Cancer Institute

Volumn 92, Issue 8, 2000, Pages 613-621

  Newschaffer, Craig J ^a,b   Otani, Koichiro ^c   McDonald, Kathleen ^c   Penberthy, Lynne T ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CAUSE OF DEATH; COHORT ANALYSIS; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

EID: 0034685534     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.8.613     Document Type: Article

References (33)

1. American Cancer Society. Cancer facts & figures, 1998. New York (NY): American Cancer Society; 1998.
2. Guralnik JM, LaCroix AZ, Everett DF, Kovar MG. Aging in the eighties: the prevalence of comorbidity and its association with disability. Advance Data 1989;170:1-8.
3. Etzioni R, Cha R, Feuer EJ, Davidov O. Asymptomatic incidence and duration of prostate cancer. Am J Epidemiol 1998;148:775-85.
4. Johansson JE, Adami HO, Andersson SO, Bergstrom R, Holmberg L, Krusemo UB. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA 1992;267:2191-6.
5. Havlik RJ, Rosenberg HM. The quality and application of death records of older persons. In: Wallace RB, Woolson RF, editors. The epidemiologic study of the elderly. New York (NY): Oxford University Press; 1993. p. 262-80.
6. Satariano WA, Ragland KE, Van Den Eeden SK. Cause of death in men diagnosed with prostate carcinoma. Cancer 1998;83:1180-8.
7. McClish DK, Penberthy L, Whittemore M, Newschaffer C, Woolard D, Desch CE, et al. Ability of Medicare claims data and cancer registries to identify cancer cases and treatment. Am J Epidemiol 1997;145:227-33.
8. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 1991;38(1 Suppl):4-8.
9. Lu-Yao GL, Barry MJ, Chang CH, Wasson JH, Wennberg JE. Transurethral resection of the prostate among Medicare beneficiaries in the United States: time trends and outcomes. Prostate Patient Outcomes Research Team (PORT). Urology 1994;44:692-8; discussion 698-9.
10. National Center for Health Statistics (NCHS). Instruction manual Part 2a. Vital statistics data preparation. Hyattsville (MD): NCHS; 1993.
11. Anderson RN, Kochanek KD, Murphy SL. Report of final mortality statistics, 1995. Monthly vital statistics report: vol. 45, No. 11, Suppl 2. Hyattsville (MD): National Center for Health Statistics; 1997.
12. Desch CD, Penberthy LP, Newschaffer CJ, Hillner BE, Whittemore M, McClish D, et al. Factors that determine treatment for local and regional prostate cancer. Med Care 1996;34:152-62.
13. Hart AC, Schmidt KM, Aaron WS, eds. St. Anthony's ICD-9-CM code book, Vol II. Reston (VA): St. Anthony's Publishing; 1998. p. 215.
14. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
15. Albertsen PC, Fryback DG, Storer BE, Kolon TF, Fine J. The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 1996;156:127-32.
16. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-9.
17. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data. J Clin Epidemiol 1997;50:725-33.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45: 613-9.
19. Malenka DJ, McLerran D, Roos N, Fisher ES, Wennberg JE. Using administrative data to describe casemix: a comparison with the medical record. J Clin Epidemiol 1994;47:1027-32.
20. Kieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H. A comparison of the Charlson comorbidity index derived from medical record data and administrative hilling data. J Clin Epidemiol 1999;52:137-42.
21. Lilienfeld DE, Stolley PD. Foundations of epidemiology. 3rd ed. New York (NY): Oxford; 1994.
22. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Boston (MA): Blackwell; 1988.
23. Percy C, Stanek E 3d, Gloeckler L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 1981;71: 242-50.
24. Percy CL, Miller BA, Gloeckler Ries LA. Effect of changes in cancer classification and the accuracy of cancer death certificates on trends in cancer mortality. Ann N Y Acad Sci 1990;609:87-97.
25. Chu KC, Horm JW, Smart C. Estimating cancer mortality rates from SEER incidence and survival data. Public Health Rep 1990;105:36-46.
26. Ries LA, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BJ, editors. SEER cancer statistics review, 1973-1991: tables and graphs, National Cancer Institute. Bethesda (MD): National Institutes of Health; 1994.
27. US Bureau of the Census. Statistical Abstract of the United States, 1995. Washington (DC): US Dept of Commerce; 1995.
28. Ron E, Carter R, Jablon S, Mabuchi K. Agreement between death certificate and autopsy diagnoses among atomic bomb survivors. Epidemiology 1994;5:48-56.
29. Kircher T, Nelson J, Burdo H. The autopsy as a measure of accuracy of the death certificate. N Engl J Med 1985;313:1263-9.
30. Schottenfeld D, Eaton M, Sommers SC, Alonso DR, Wilkinson C. The autopsy as a measure of accuracy of the death certificate. Bull N Y Acad Med 1982;58:778-94.
31. Perenger TV. What's wrong with Bonferroni adjustments. BMJ 1998;316: 1236-8.
32. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
33. Goodman SN, Royall R. Evidence and scientific research. Am J Public Health 1988;78:1568-74.